Abcellera Biologicsinc Stock Working Capital
| ABCL Stock | USD 3.95 0.11 2.86% |
Abcellera BiologicsInc fundamentals help investors to digest information that contributes to Abcellera BiologicsInc's financial success or failures. It also enables traders to predict the movement of Abcellera Stock. The fundamental analysis module provides a way to measure Abcellera BiologicsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abcellera BiologicsInc stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 753 M | 585.3 M | |
| Change In Working Capital | 13.2 M | 13.9 M | |
| Working Capital | 0.00 | 0.00 |
Abcellera | Working Capital |
Abcellera BiologicsInc Company Working Capital Analysis
Abcellera BiologicsInc's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Abcellera BiologicsInc Working Capital | 752.97 M |
Most of Abcellera BiologicsInc's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abcellera BiologicsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Abcellera Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Abcellera BiologicsInc is extremely important. It helps to project a fair market value of Abcellera Stock properly, considering its historical fundamentals such as Working Capital. Since Abcellera BiologicsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abcellera BiologicsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abcellera BiologicsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Abcellera Capital Lease Obligations
Capital Lease Obligations |
|
In accordance with the company's disclosures, Abcellera BiologicsInc has a Working Capital of 752.97 M. This is 76.9% higher than that of the Biotechnology sector and 39.8% higher than that of the Health Care industry. The working capital for all United States stocks is 49.06% higher than that of the company.
Abcellera Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abcellera BiologicsInc's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abcellera BiologicsInc could also be used in its relative valuation, which is a method of valuing Abcellera BiologicsInc by comparing valuation metrics of similar companies.Abcellera BiologicsInc is currently under evaluation in working capital category among related companies.
Abcellera Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0979 | ||||
| Operating Margin | (7.20) % | ||||
| Current Valuation | 499.63 M | ||||
| Shares Outstanding | 294.05 M | ||||
| Shares Owned By Insiders | 27.90 % | ||||
| Shares Owned By Institutions | 42.91 % | ||||
| Number Of Shares Shorted | 23.09 M | ||||
| Price To Earning | 16.67 X | ||||
| Price To Book | 1.10 X | ||||
| Price To Sales | 33.42 X | ||||
| Revenue | 38.02 M | ||||
| Gross Profit | 311.11 M | ||||
| EBITDA | (192.16 M) | ||||
| Net Income | (146.4 M) | ||||
| Cash And Equivalents | 868.21 M | ||||
| Cash Per Share | 3.04 X | ||||
| Total Debt | 77.38 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 9.86 X | ||||
| Book Value Per Share | 3.96 X | ||||
| Cash Flow From Operations | (43.88 M) | ||||
| Short Ratio | 23.23 X | ||||
| Earnings Per Share | (0.51) X | ||||
| Price To Earnings To Growth | 2.22 X | ||||
| Target Price | 15.38 | ||||
| Number Of Employees | 586 | ||||
| Beta | 0.36 | ||||
| Market Capitalization | 1.13 B | ||||
| Total Asset | 1.49 B | ||||
| Retained Earnings | 279.79 M | ||||
| Working Capital | 752.97 M | ||||
| Net Asset | 1.49 B |
About Abcellera BiologicsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abcellera BiologicsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abcellera BiologicsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abcellera BiologicsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Abcellera BiologicsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcellera BiologicsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera BiologicsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Abcellera Stock
| 0.79 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
Moving against Abcellera Stock
| 0.87 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.82 | RVMD | Revolution Medicines Financial Report 13th of May 2024 | PairCorr |
| 0.63 | ELYM | Eliem Therapeutics | PairCorr |
| 0.57 | INDP | Indaptus Therapeutics | PairCorr |
| 0.49 | FBRX | Forte Biosciences Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Abcellera BiologicsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcellera BiologicsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcellera BiologicsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcellera BiologicsInc to buy it.
The correlation of Abcellera BiologicsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera BiologicsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera BiologicsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abcellera BiologicsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Abcellera BiologicsInc Piotroski F Score and Abcellera BiologicsInc Altman Z Score analysis. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.